0001193125-11-138919.txt : 20110513 0001193125-11-138919.hdr.sgml : 20110513 20110513113206 ACCESSION NUMBER: 0001193125-11-138919 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110331 FILED AS OF DATE: 20110513 DATE AS OF CHANGE: 20110513 EFFECTIVENESS DATE: 20110513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Abingworth LLP CENTRAL INDEX KEY: 0001397144 IRS NUMBER: 980518585 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-14285 FILM NUMBER: 11838898 BUSINESS ADDRESS: STREET 1: 38 JERMYN STREET CITY: LONDON STATE: X0 ZIP: SW1Y 6DN BUSINESS PHONE: 44 (0)20 7534 1500 MAIL ADDRESS: STREET 1: 38 JERMYN STREET CITY: LONDON STATE: X0 ZIP: SW1Y 6DN 13F-HR 1 d13fhr.txt FORM 13F ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2011 Check here if Amendment [_]; Amendment Number: ________________________________ This Amendment (Check only one.): [_] is a restatement. [_] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Abingworth LLP Address: Princes House, 38 Jermyn Street, London, England SW1Y 6DN Form 13F File Number: 28-14285 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: James Abell Title: Member Phone: +44 (0)20 7534 1500 Signature, Place, and Date of Signing: /s/ James Abell London, United Kingdom May 9, 2011 ----------------------- ------------------------ ----------------------- (Name) (City, State) (Date) Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) ================================================================================ FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 1 Form 13F Information Table Entry Total: 27 items Form 13F Information Table Value Total: $195,981 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Form 13F File Number Name 1 Not applicable Abingworth Management Limited FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 -------- --------- --------- -------- ------------------- ---------- -------- ---------------------- VOTING AUTHORITY TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER ---------------------- NAME OF ISSUER CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE -------------- --------- --------- -------- ---------- --- ---- ---------- -------- ---------- ------ ---- AFFYMETRIX INC COM 00826T108 1,281 246,253 SH DEFINED 1 246,253 ALEXZA PHARMACEUTICALS INC COM 15384100 4,849 2,869,207 SH DEFINED 1 2,869,207 ALLOS THERAPEUTICS INC COM 19777101 837 265,000 SH DEFINED 1 265,000 ALNYLAM PHARMACEUTICALS INC COM 02043Q107 17,342 1,814,053 SH DEFINED 1 1,814,053 AMARIN CORP PLC SPONS ADR 23111206 88,148 12,075,000 SH DEFINED 1 12,075,000 AVANIR PHARMACEUTICALS INC CL A 05348P401 458 112,500 SH DEFINED 1 112,500 CELLDEX THERAPEUTICS INC COM 15117B103 1,380 343,396 SH DEFINED 1 343,396 CALIPER LIFE SCIENCES INC COM 130872104 4,242 627,501 SH DEFINED 1 627,501 CARDIOME PHARMA CORP COM 14159U202 2,053 480,856 SH DEFINED 1 480,856 CELGENE CORP COM 151020104 5,235 90,994 SH DEFINED 1 90,994 CORNERSTONE THERAPEUTICS INC COM 21924P103 561 84,742 SH DEFINED 1 84,742 ENTREMED INC COM 29382F202 362 70,760 SH DEFINED 1 70,760 EXELIXIS INC COM 30161Q104 4,685 415,000 SH DEFINED 1 415,000 INCYTE CORP COM 45337C102 13,154 830,417 SH DEFINED 1 830,417 ISIS PHARMACEUTICALS INC NOTE 464337AE4 1,229 1,280 PRN DEFINED 1 1,280 ISIS PHARMACEUTICALS INC COM 464330109 2,416 267,578 SH DEFINED 1 267,578 MICROMET INC COM 59509C105 9,396 1,677,860 SH DEFINED 1 1,677,860 NEKTAR THERAPEUTICS COM 640268108 6,281 663,946 SH DEFINED 1 663,946 NOVAVAX INC COM 670002104 3,895 1,503,824 SH DEFINED 1 1,503,824 NPS PHARMACEUTICALS INC COM 62936P103 4,761 497,500 SH DEFINED 1 497,500 ONCOGENEX PHARMACEUTICALS INC COM 68230A106 6,826 447,590 SH DEFINED 1 447,590 PONIARD PHARMACEUTICALS INC COM 732449301 77 182,239 SH DEFINED 1 182,239 SUNESIS PHARMACEUTICALS INC COM 867328502 248 129,358 SH DEFINED 1 129,358 MEDICINES CO COM 584688105 1,742 107,000 SH DEFINED 1 107,000 TRIMERIS INC COM 896263100 794 320,000 SH DEFINED 1 320,000 ZALICUS INC COM 98887C105 2,100 864,044 SH DEFINED 1 864,044 ZOGENIX INC COM 98978L105 11,629 2,335,218 SH DEFINED 1 2,335,218